BLOG

Japan’s Regenerative Medicine Law and Adipose Stem Cell Therapy

Published 2026.10.11 7 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

If you are considering adipose-derived stem cell therapy in Japan, you may have heard that the country has a dedicated legal framework for regenerative medicine. Understanding how that framework works can help you ask better questions before you travel or book a consultation. This article explains, in general terms, how Japan’s regenerative medicine law relates to treatment using cultured mesenchymal stem cells taken from your own fat tissue, and what you may want to confirm with a doctor at Grand Green Osaka Umekita Clinic in Osaka.

The short answer: a plan-based system with oversight

In Japan, regenerative medicine that uses cells is generally provided under the Act on the Safety of Regenerative Medicine, sometimes referred to in English as the Regenerative Medicine Safety Act. In simple terms, a medical institution that wants to offer a treatment of this kind prepares a regenerative medicine provision plan. The plan describes what the treatment is, how cells are collected and processed, and how patients are informed. The plan is then reviewed by a certified committee and submitted to the Ministry of Health, Labour and Welfare.

This system is a framework for oversight and transparency. It does not mean that a treatment is proven to work for every person, and it does not replace a physician’s individual assessment. Adipose-derived stem cell therapy is provided as a self-pay treatment, which means it is not covered by Japan’s public health insurance. Costs, risks, possible side effects, and whether the treatment is appropriate for you must all be confirmed through a medical consultation.

How the law connects to the steps of treatment

It can be useful to see how the legal framework relates to each stage of adipose stem cell therapy. The treatment described on the clinic’s page involves collecting a very small amount of your own fat tissue under local anesthesia, culturing and expanding the mesenchymal stem cells at a specialized facility, and then returning the cells by intravenous infusion on an outpatient basis.

Collection: a small amount of fat tissue is taken by a doctor, with explanation and consent beforehand.
Culture: cells are processed at a facility that is expected to meet the standards described in the provision plan.
Infusion: the cultured cells are given by IV drip, and your condition is observed afterward.
Follow-up: the institution is expected to record and manage information about the treatment and any health concerns that follow.

Because these steps involve a separate culture facility, it is reasonable to ask how the clinic works with that facility and what quality checks are carried out. Our related article on cell culture and quality checks looks at that stage in more detail.

What the law does not tell you

A regulated framework is helpful context, but it has limits that patients should understand. Research on mesenchymal stem cells is active worldwide, and many findings come from laboratory studies or early-stage clinical research. Reports that these cells may secrete anti-inflammatory substances or growth factors do not mean that any individual will experience a particular outcome.

For that reason, you should be cautious about any source that describes regenerative medicine as a cure or promises results. A trustworthy explanation will describe both the potential and the uncertainty. Adipose stem cell therapy is also not a substitute for standard medical care for a diagnosed condition. If you are currently being treated for a disease, you should talk with your regular physician about how any additional treatment fits with your care.

Questions to ask before you decide

A consultation is the place to turn general information into a decision that fits your own circumstances. The following questions can help you prepare.

Is this treatment provided under a regenerative medicine provision plan, and can I see an explanation of it?
What is the purpose of the treatment in my situation, and what are the realistic limits?
What are the possible risks and side effects, and how are they monitored and handled after infusion?
What will the total cost be, including consultation, collection, culture, infusion, and follow-up visits?
How many visits are needed, how long does the process take, and what happens if I cannot return to Osaka?
Are there medical conditions or medications that mean I should not receive this treatment?

Bringing your medical history, a list of your current medications, and any recent test results can help the doctor give you a more accurate explanation. Please also tell the doctor about allergies and any past reactions to anesthesia.

Support for international patients in Osaka

Grand Green Osaka Umekita Clinic is located in the Umeda area of Osaka, which is easy to reach from Kansai International Airport and Shin-Osaka Station. The clinic provides an information page for international patients, and English-language materials are available so that you can review the treatment overview, flow, and fees before contacting the clinic. If you have questions about how the legal framework applies, or if you need help understanding consent documents, it is a good idea to ask in advance how language support will be arranged during your visit.

If you are planning to travel, remember that regenerative treatment involves more than a single appointment. Allow time for the consultation, collection, culture period, infusion, and any follow-up your doctor recommends. You can find the latest information on fees and the treatment flow on the clinic’s adipose-derived stem cell therapy page.

Key points to remember

Japan’s regenerative medicine framework requires institutions to prepare and submit a provision plan, which adds structure and oversight to treatments such as adipose-derived stem cell therapy. It is not a promise of results. Treatment is self-pay, individual suitability is decided by a doctor, and costs, risks, and side effects should be explained to you in full before you agree to anything. If you would like to learn more, a consultation with a physician is the best next step, and you may review the clinic’s treatment page beforehand to prepare your questions.

Before You Decide

Provision plan frameworkOversight, not a promise of results
Self-pay treatmentNot covered by public insurance
Risks and side effectsConfirm before agreeing
Doctor consultationSuitability is decided individually

This figure is a conceptual summary of the article content

Learn more about Adipose-Derived Stem Cell Therapy

References

Supervising Physician

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Back to article list › Back to Adipose-Derived Stem Cell Therapy ›